We are live on ! Find out more
FLNA

Filana Therapeutics
FLNA

31 hedge funds and large institutions have $24.2M invested in Filana Therapeutics in 2019 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

997% more capital invested

Capital invested by funds: $2.21M → $24.2M (+$22M)

267% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 3

80% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 5

35% more funds holding

Funds holding: 23 → 31 (+8)

16.08% more ownership

Funds ownership: 10.6% → 26.68% (+16%)

Holders
31
Holders Change
+8
Holders Change %
+34.78%
% of All Funds
0.61%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
11
Increased
9
Reduced
5
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CH
CVI Holdings
Delaware
+$781K
2
Renaissance Technologies
Renaissance Technologies
New York
+$283K
3
BlackRock
BlackRock
New York
+$168K
4
ECM
ExodusPoint Capital Management
New York
+$162K
5
Two Sigma Investments
Two Sigma Investments
New York
+$138K

Top Sellers

Rank Fund Capital Flow
1
WVP
Worth Venture Partners
New Jersey
-$220K
2
ARTA
A.R.T. Advisors
New York
-$29K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$15K
4
Envestnet Asset Management
Envestnet Asset Management
Illinois
-$8.11K
5
Bank of America
Bank of America
North Carolina
-$3.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
BL
1
Bleichroeder LP
New York
$9.05M +$3M +1,739,540 New
Renaissance Technologies
2
Renaissance Technologies
New York
$5.28M +$283K +163,801 +19%
CH
3
CVI Holdings
Delaware
$2.35M +$781K +452,246 New
WVP
4
Worth Venture Partners
New Jersey
$1.49M -$220K -127,179 -35%
BlackRock
5
BlackRock
New York
$1.48M +$168K +97,538 +52%
Vanguard Group
6
Vanguard Group
Pennsylvania
$940K +$10.7K +6,178 +4%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$750K +$120K +69,519 +93%
ECM
8
ExodusPoint Capital Management
New York
$488K +$162K +93,780 New
Two Sigma Investments
9
Two Sigma Investments
New York
$416K +$138K +80,067 New
JG
10
Jefferies Group
New York
$364K +$121K +70,000 New
Marshall Wace
11
Marshall Wace
United Kingdom
$284K +$94.4K +54,669 New
Envestnet Asset Management
12
Envestnet Asset Management
Illinois
$253K -$8.11K -4,700 -9%
Two Sigma Advisers
13
Two Sigma Advisers
New York
$203K +$67.5K +39,075 New
Millennium Management
14
Millennium Management
New York
$139K +$46.1K +26,719 New
Northern Trust
15
Northern Trust
Illinois
$120K +$9.3K +5,390 +30%
Bank of New York Mellon
16
Bank of New York Mellon
New York
$115K – – –
CAN
17
Cetera Advisor Networks
California
$109K +$36.3K +21,000 New
Jane Street
18
Jane Street
New York
$90K +$5.66K +3,279 +23%
Acadian Asset Management
19
Acadian Asset Management
Massachusetts
$79K +$26.3K +15,207 New
California Public Employees Retirement System
20
California Public Employees Retirement System
California
$74K – – –
Morgan Stanley
21
Morgan Stanley
New York
$33K -$729 -422 -6%
Bank of America
22
Bank of America
North Carolina
$19K -$3.7K -2,143 -37%
Carson Wealth (CWM LLC)
23
Carson Wealth (CWM LLC)
Nebraska
$17K – – –
UBS Group
24
UBS Group
Switzerland
$14K +$4.17K +2,417 +833%
LTFS
25
Ladenburg Thalmann Financial Services
Florida
$11K – – –
1
2

FLNA Hedge Fund Activity: Q4 2019 in Review

31 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q4 2019, worth a combined $24.2M — up 997% from $2.21M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new FLNA positions and 3 closed out — a net gain of 8 holders — while 9 added to existing stakes and 5 trimmed.

The largest buyer was CVI Holdings, opening a new position worth an estimated $781K. The largest seller was Worth Venture Partners, cutting an estimated $220K.

  • 31 institutional investors held Filana Therapeutics (FLNA) as of Q4 2019, up from 23 in Q3 2019.
  • Funds reported $24.2M of Filana Therapeutics stock for Q4 2019, up 997% quarter-over-quarter.
  • 11 funds opened new Filana Therapeutics positions in Q4 2019 and 3 closed out, a net change of +8 holders.
  • The largest Filana Therapeutics buyer in Q4 2019 was CVI Holdings, an estimated $781K added.
  • The largest Filana Therapeutics seller in Q4 2019 was Worth Venture Partners, an estimated $220K sold.

Based on aggregated 13F filings for Q4 2019.